Hypermutation and gene conversion appear to be distinct mechanisms that can explain somatic diversification of the antibody repertoire. Data in a recent Nature paper suggest unappreciated links between the two.
References
Muramatsu, M. et al. Cell 102, 553–563 (2000).
Papavasiliou, F. N. & Schatz, D. G. Nature 408, 216–221 (2000).
Bross, L. et al. Immunity 13, 589–597 (2000).
Sale, J. E., Calandrini, D. M., Takata, M., Takeda, S. & Neuberger, M. S. Nature 412, 921–926 (2001).
Maizels, N. Cell 83, 9–12 (1995).
Weill, J. C. & Reynaud, C. A. Immunol. Today 17, 92–97 (1996).
Holbeck, S. L. & Strathern, J. N. Genetics 147, 1017–1024 (1997).
Sonoda, E. et al. Mol. Cell Biol. 19, 5166–5169 (1999).
Takata, M. et al. Mol. Cell Biol. 21, 2858–2866 (2001).
Bemark, M. et al. J. Exp. Med. 192, 1509–1514 (2000).
Pâques, F. & Haber, J. E. Microbiol. Mol. Biol. Rev. 63, 349–404 (1999).
Michel, B. Trends Biochem. Sci. 25, 173–178 (2000).
Dalgaard, J. Z. & Klar, A. J. Trends Genet. 17, 153–157 (2001).
Rada, C., Ehrenstein, M.R., Neuberger, M.S. & Milstein, C. Immunity 9, 135–141 (2000).
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Haber, J. Hypermutation: give us a break. Nat Immunol 2, 902–903 (2001). https://doi.org/10.1038/ni1001-902
Issue Date:
DOI: https://doi.org/10.1038/ni1001-902
- Springer Nature America, Inc.
This article is cited by
-
Targeting of somatic hypermutation
Nature Reviews Immunology (2006)